The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer

Abstract Objective To comprehend the effects of diverse therapeutic interventions on thromboelastography (TEG) and conventional coagulation parameters among individuals diagnosed with colorectal cancer, this study aims to explore the clinical relevance of both thromboelastography and conventional co...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenqin Ren, Hao Chen, Yujie Huang, Jiaqian Zuo, Xinyan Shu, Peng Shu
Format: Article
Language:English
Published: Springer 2024-12-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-024-01311-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433190965444608
author Wenqin Ren
Hao Chen
Yujie Huang
Jiaqian Zuo
Xinyan Shu
Peng Shu
author_facet Wenqin Ren
Hao Chen
Yujie Huang
Jiaqian Zuo
Xinyan Shu
Peng Shu
author_sort Wenqin Ren
collection DOAJ
description Abstract Objective To comprehend the effects of diverse therapeutic interventions on thromboelastography (TEG) and conventional coagulation parameters among individuals diagnosed with colorectal cancer, this study aims to explore the clinical relevance of both thromboelastography and conventional coagulation metrics in evaluating coagulation function and predicting the incidence of thrombotic and hemorrhagic events in patients with colorectal cancer. Methods A cohort of 122 patients with colorectal cancer retrospectively recruited and divided into 2 groups: those undergoing surgical intervention (operation group) and those not subjected to surgery (non-operation group). According to the different types of treatment they received, the operation group was divided into chemotherapy-only group and a group receiving a combination of targeted therapy and chemotherapy. Blood samples were collected on admission and subjected to coagulation parameter assessment, including conventional coagulation tests and thromboelastography (TEG) assessment. Receiver operating characteristic (ROC) analysis was performed to predict the occurrence of complications in patients with colorectal cancer. Results Compared with the operation group, the non-operation group showed significant reductions in reaction time(R-time) and kinetics time (K-time), and significant elevation in angle, maximum amplitude (MA), fibrinogen and platelets. Patients receiving targeted therapy and chemotherapy had lower angle and maximum amplitude and higher R-time and K-time, activated partial thromboplastin time and fibrinogen. The area under the curve for TEG in patients without treatment was 0.802. The area under the curve for TEG and conventional coagulation parameters were 0.654 and 0.660 respectively. Conclusion Diverse treatments distinctly impact on the coagulation indicators of individuals diagnosed with colorectal cancer. The coagulation parameters observed in patients prior to operation suggest a hypercoagulable state. Nevertheless, following postoperative chemotherapy and targeted therapy, this hypercoagulable state demonstrates a notable improvement, occasionally leading to a propensity for hypocoagulation. The findings of this investigation underscore the unique clinical importance of thromboelastography (TEG) alongside traditional coagulation parameters, demonstrating that these diagnostic tools possess complementary value and cannot be substituted interchangeably.
format Article
id doaj-art-af2f1318946248e1b0cc4ce86e98f4ae
institution Kabale University
issn 2730-6011
language English
publishDate 2024-12-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-af2f1318946248e1b0cc4ce86e98f4ae2025-08-20T03:27:09ZengSpringerDiscover Oncology2730-60112024-12-011511910.1007/s12672-024-01311-7The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancerWenqin Ren0Hao Chen1Yujie Huang2Jiaqian Zuo3Xinyan Shu4Peng Shu5Nanjing University of Chinese MedicineDepartment of Clinical Laboratory, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese MedicineNanjing University of Chinese MedicineNanjing University of Chinese MedicineNanjing University of Chinese MedicineDepartment of Oncology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese MedicineAbstract Objective To comprehend the effects of diverse therapeutic interventions on thromboelastography (TEG) and conventional coagulation parameters among individuals diagnosed with colorectal cancer, this study aims to explore the clinical relevance of both thromboelastography and conventional coagulation metrics in evaluating coagulation function and predicting the incidence of thrombotic and hemorrhagic events in patients with colorectal cancer. Methods A cohort of 122 patients with colorectal cancer retrospectively recruited and divided into 2 groups: those undergoing surgical intervention (operation group) and those not subjected to surgery (non-operation group). According to the different types of treatment they received, the operation group was divided into chemotherapy-only group and a group receiving a combination of targeted therapy and chemotherapy. Blood samples were collected on admission and subjected to coagulation parameter assessment, including conventional coagulation tests and thromboelastography (TEG) assessment. Receiver operating characteristic (ROC) analysis was performed to predict the occurrence of complications in patients with colorectal cancer. Results Compared with the operation group, the non-operation group showed significant reductions in reaction time(R-time) and kinetics time (K-time), and significant elevation in angle, maximum amplitude (MA), fibrinogen and platelets. Patients receiving targeted therapy and chemotherapy had lower angle and maximum amplitude and higher R-time and K-time, activated partial thromboplastin time and fibrinogen. The area under the curve for TEG in patients without treatment was 0.802. The area under the curve for TEG and conventional coagulation parameters were 0.654 and 0.660 respectively. Conclusion Diverse treatments distinctly impact on the coagulation indicators of individuals diagnosed with colorectal cancer. The coagulation parameters observed in patients prior to operation suggest a hypercoagulable state. Nevertheless, following postoperative chemotherapy and targeted therapy, this hypercoagulable state demonstrates a notable improvement, occasionally leading to a propensity for hypocoagulation. The findings of this investigation underscore the unique clinical importance of thromboelastography (TEG) alongside traditional coagulation parameters, demonstrating that these diagnostic tools possess complementary value and cannot be substituted interchangeably.https://doi.org/10.1007/s12672-024-01311-7Colorectal cancerChemotherapyTargeted therapyThromboelastographyConventional coagulation parameters
spellingShingle Wenqin Ren
Hao Chen
Yujie Huang
Jiaqian Zuo
Xinyan Shu
Peng Shu
The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
Discover Oncology
Colorectal cancer
Chemotherapy
Targeted therapy
Thromboelastography
Conventional coagulation parameters
title The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
title_full The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
title_fullStr The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
title_full_unstemmed The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
title_short The impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
title_sort impact of different treatments on thromboelastography and other conventional parameters in patients with colorectal cancer
topic Colorectal cancer
Chemotherapy
Targeted therapy
Thromboelastography
Conventional coagulation parameters
url https://doi.org/10.1007/s12672-024-01311-7
work_keys_str_mv AT wenqinren theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT haochen theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT yujiehuang theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT jiaqianzuo theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT xinyanshu theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT pengshu theimpactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT wenqinren impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT haochen impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT yujiehuang impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT jiaqianzuo impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT xinyanshu impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer
AT pengshu impactofdifferenttreatmentsonthromboelastographyandotherconventionalparametersinpatientswithcolorectalcancer